Delivery Order SPE2DB22D3401-SPE2DB24FT2NV
Award Date 4/8/24
Potential Completion Date 4/9/24
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product. The $4,455.88 order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract has a potential value of $3,705.92 and a performance period through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,770.89 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The contract, valued at $2,770.74, has a completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The $2,062.69 contract has a performance period through March 5, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA (CF) PEN 40 MG/0.4 MLS pharmaceutical products. The delivery order has a ceiling value of $7,103.91 and a period of performance through March 20, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The $3,734.86 delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables AmerisourceBergen to deliver a comprehensive range of medications and medical supplies to DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS. The $8,529.98 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals. The $37,464.31 contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The $6,558.30 delivery order has a completion date of January 23, 2024 and was awarded on January 22, 2024. The delivery order is part of AmerisourceBergen Drug Corp's existing indefinite delivery contract to supply pharmaceuticals and medical supplies to DLA Troop...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2NVDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. This $6,369.88 contract has an ultimate completion date of April 9, 2024 and was awarded on April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was not set aside for any specific program or business type.
Generated 7/8/24, 9:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 4/8/24 |